Israel and Hamas agreed to a ceasefire and implemented the first phase of the truce on January 19, 2025, after a three-hour ...

Then, in Phase 2, the U.S. Army Corps of Engineers will be able to move in and physically remove the debris from properties ...

The EU-backed tExtended project to address the rising problem of textile waste has entered the second phase of its mission ...

A new route to downtown Burlington that has been decades in the making is expected to be completed by next year. But before ...

Hamas reportedly seeks release of archterrorist serving 5 life sentences for the murders he committed because they believe he ...

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Cullinan Therapeutics has announced that its lead asset has aced a midstage lung cancer trial—but the biotech is keeping the ...

Douglas Tsao, an analyst from H.C. Wainwright, reiterated the Buy rating on Coherus Biosciences (CHRS – Research Report). The associated price ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...